ADMA NASDAQ
ADMA Biologics, Inc.
1W: -0.5%
1M: +10.4%
3M: +28.2%
YTD: -37.5%
1Y: -26.4%
3Y: +253.5%
5Y: +906.3%
$11.17
+0.10 (+0.95%)
Weekly Expected Move ±5.8%
$9
$10
$11
$11
$12
Credit Risk of going bust: lower than 58% of companies Debt: 7.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.10 (down 99.1%), ADMA Biologics, Inc. would be worth roughly what it owes.
Total debt $203.8M against a stock market value of $2.50B.
Distance to default 5.92 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $100.2M (short-term plus half of long-term), stock volatility 55.4%; Altman Z'' 7.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.10 (down 99.1%), ADMA Biologics, Inc. would be worth roughly what it owes.
Total debt $203.8M against a stock market value of $2.50B.
Distance to default 5.92 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $100.2M (short-term plus half of long-term), stock volatility 55.4%; Altman Z'' 7.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-05-28
Earliest Filing
2021-12-21
Latest Filing
partner: 3
Counterparties (Filed by ADMA)
3 relationshipsCompanies named in ADMA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Continental Stock Transfer and Trust Company | — | partner | Serves as rights agent for the Rights Agreement | 2021-12-21 | View |
| Raymond James & Associates, Inc. | — | partner | Agent for the distribution of common stock shares under a Distribution Agreement. | 2021-09-03 | View |
| Jefferies LLC | JEF | partner | Agent for the Open Market Sale Agreement | 2021-05-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-02 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-05-04 | Other Events; Exhibits | View | |
| 2026-03-27 | Regulation FD; Exhibits | View | |
| 2026-03-02 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Results of O | Agreement | View |
| 2025-06-04 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-28 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-21 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-01-02 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-12-20 | Other Events; Financial Statements and Exhibits | View | |
| 2024-11-21 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR